Breaking News
Quick Take: Gold from lead and ancient alchemy
HEALTH SECRETS: How to Instantly Block MSG Toxicity Using Natural Substances...
STEATOTIC LIVER DISEASE stems from people who scarf down a whole meal in less than 5 minutes...
Newsom to SEIZE MALIBU COAST to build massive 15-minute city after weather weapons destroyed...
Top Tech News
Cavorite X7 makes history with first fan-in-wing transition flight
Laser-powered fusion experiment more than doubles its power output
Watch: Jetson's One Aircraft Just Competed in the First eVTOL Race
Cab-less truck glider leaps autonomously between road and rail
Can Tesla DOJO Chips Pass Nvidia GPUs?
Iron-fortified lumber could be a greener alternative to steel beams
One man, 856 venom hits, and the path to a universal snakebite cure
Dr. McCullough reveals cancer-fighting drug Big Pharma hopes you never hear about…
EXCLUSIVE: Raytheon Whistleblower Who Exposed The Neutrino Earthquake Weapon In Antarctica...
Doctors Say Injecting Gold Into Eyeballs Could Restore Lost Vision
No Trial Data, No Vax: FDA Demands Gold Standard Testing For Any New COVID-19 Vaccines
Authored by Zachary Stieber via The Epoch Times (emphasis ours),
The Food and Drug Administration (FDA) will not approve COVID-19 vaccines for many Americans absent trial data showing that the benefits outweigh the risks, top agency officials said on May 20.
"Moving forward, the FDA will adopt the following Covid-19 vaccination regulatory framework: On the basis of immunogenicity—proof that a vaccine can generate antibody titers in people—the FDA anticipates that it will be able to make favorable benefit–risk findings for adults over the age of 65 years and for all persons above the age of 6 months with one or more risk factors that put them at high risk for severe Covid-19 outcomes," such as asthma or cancer, FDA Commissioner Dr. Marty Makary and Dr. Vinay Prasad, head of the FDA's Center for Biologics Evaluation and Research, wrote in a New England Journal of Medicine article.